Biotechnology

R&D in Micropoint Biotechnology includes strong collaboration with groups of researchers and scientists around the world to develop novel biomarkers and antibodies that are customized to meet the rapid diagnostic needs. These co-development programs encompass sets/libraries of bio-markers screening, cell line engineering, protein expression, and bio-processing.

Micropoint will continue to work with our partners to develop novel bio-markers and antibodies with high affinity and high specificity in each of the following steps:

• Hybridoma development
• Polyclonal antibody
• Antibody purification
• Antibody Fragmentation and isotyping
• Conjugation and labeling
• Immune response testing
• Novel assay development
• Bio-signal amplifications